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Introduction {#sec001}
============

Leishmaniasis imposes a major health impact all over the tropical and subtropical regions of the world \[[@pone.0192236.ref001]\]. An estimated 0.9 to 1.3 million new cases and 20000 to 30000 deaths occur annually in the world \[[@pone.0192236.ref002]\]. Cutaneous leishmaniasis (CL) is the most common form of the disease which constitutes approximately 75% of the global cases. Anthroponotic cutaneous leishmaniasis (ACL) caused by *Leishmania tropica* and zoonotic cutaneous leishmaniasis (ZCL) caused by *Leishmania major* are endemic in many parts of Iran with high outbreak rates \[[@pone.0192236.ref003]--[@pone.0192236.ref006]\]. Therefore, CL has recently become an important health issue in the country. Recently, its incidence has risen considerably and is expanding to new foci \[[@pone.0192236.ref007]\].

Poverty-stricken individuals are commonly affected by this disease due to their malnutrition, nomadic life, feint immune system, and lack of living standards \[[@pone.0192236.ref002]\]. The population at the risk of CL in countries with high burden varies between 14 and 100%. It means that approximately 399 million people are subjected to the risk of CL. The highest CL incidence has been reported in Syria with 22.74 per 10000 people, while in Iran it is 2.68 per 10000 people. Based on the recent statistics in CL-high-burden countries, the cases have tripled over the past two decades \[[@pone.0192236.ref008]\]. ACL has been reported for many years and can be considered as a classic form of the disease in Iran \[[@pone.0192236.ref001]\]. In urban places, located at higher altitudes, CL is caused by *L*. *tropica* which is spread in an anthroponotic cycle from human to human by female sand fly bites, *Phlebotomus sergenti* \[[@pone.0192236.ref003]\]. The disease is associated with socioeconomic, religious, cultural, demographic, and environmental factors. Migration of laborers from rural to urban areas for occupational reasons remains a significant risk determinant as well as civil unrest and climate changes for ACL \[[@pone.0192236.ref009]\].

In Iran, meglumine antimoniate (Glucantime) is the first-line treatment for CL and visceral leishmaniasis (VL), either systemically alone or intra-lesionally along with cryotherapy \[[@pone.0192236.ref010],[@pone.0192236.ref011]\]. Patients with CL lesions not responding to pentavalent antimonials treatment have been reported \[[@pone.0192236.ref007]\]. These patients certainly need effective alternative treatment modalities. Although the disease is a treatable non-healing forms of CL which frequently occur \[[@pone.0192236.ref010]\]. The treatment of CL is also related to several factors such as geographic modification (environmental factors), type and clinical status of disease, and parasite species \[[@pone.0192236.ref002]\]. The objective of this study was to investigate the role of environmental, clinical, and demographic characteristic risk factors in creating unresponsive forms when compared with responsive group among patients with ACL in a major focus in southeastern Iran. To our knowledge, the present work is the first study on associated risk-related factors among unresponsive and responsive patients at a national and international level.

Materials and methods {#sec002}
=====================

Study design {#sec003}
------------

A case-control study was conducted from April 2015 to October 2016 from 10 high risk zones of Kerman district, in the southeast of Iran.

Ethical consideration {#sec004}
---------------------

Ethical approval was granted by the joint Ethical Committees of Kerman University of Medical Sciences and Kerman Leishmaniasis Research Center (ethic no. IR.KMU.REC.1394.115, contract no. 94.621). Initially, several face-to-face meetings and interviews with the volunteers and community authorities were organized. In the meetings, the purposes of the study, procedure, and potential benefits were described. Accordingly, patients with CL were treated free of charge with the correct drugs. Those who were suspected of having other underlying diseases were referred to provincial hospitals for further follow-up examinations. Patients with CL willingly participated in the survey. For each patient, a written informed consent form was completed. All demographic and clinical data were kept confidential. Moreover, parents/guardians provided informed consent "on behalf\" of all the children that participated.

Study site {#sec005}
----------

Kerman province is located in southeast Iran, in the southwest of the Kavir-e Lut. This province falls into the arid and semi-arid zones and suffers from scarcity of water, conditions like much of the Iranian plateau. The average annual rainfall is low and decreases toward the southeast, although the topography gives rise to many local variations. Maximum precipitation occurs in winter; the annual average is 142 mm in Kerman. In the province, leishmaniasis is common and also very old. Two major ACL foci are present in the province of Kerman including the Kerman and Bam districts \[[@pone.0192236.ref012]\].

Questionnaire {#sec006}
-------------

The survey questionnaires were based on the leishmaniasis indicator household questionnaires. Some of the questions of the questionnaire were selected based on previous studies \[[@pone.0192236.ref013],[@pone.0192236.ref014]\]. Other questions were selected according to the importance of health issues associated with environmental, demographical, and clinical field of leishmaniasis from the expert's points of view ([S1 Table](#pone.0192236.s003){ref-type="supplementary-material"}). Also, the content was evaluated by researchers from different fields (epidemiology, parasitology, and dermatology) in terms of its validity. Before the start of the survey and questioning, several coordinating intra-group meetings were held among the research group to limit the intra evaluation errors. Necessary explanations about the investigation were given to the patients or their parents (guardians). Afterwards, the questioning process proceeded. During the questioning process, the questioner made sure the patients well-understood the questions. Data were collected through house-to-house visits and interviews via structured questionnaires together with direct observation of housing and environmental conditions with permission of the households\' heads. The data were accurately recorded by the first author in the questionnaire.

The questionnaire included environmental, clinical, and demographic characteristic risk factors. The 25 risk factors include building, wall, door, window, and interior housing conditions, out of building toilet, presence of small garden, dwelling hygienic condition, number of windows and rooms, presence of domestic animals, dog and manure in home, solid waste management, presence of dogs in close vicinity, duration, number and location of the lesions, treatment conditions, history of chronic diseases, age, sex, education, job, and marital status.

Unresponsive and responsive participants {#sec007}
----------------------------------------

Patients were recruited in a major ACL focus from unresponsive (case) and responsive (control) ACL cases. Unresponsive patient is one who does not heal and remains with an active lesion, despite receiving two courses of intra-lesional Glucantime along with cryotherapy and one cycle of systemic Glucantime ([Fig 1](#pone.0192236.g001){ref-type="fig"}). Responsive patient is one whose lesion heals by one treatment cycle with intramuscular administration of Glucantime or intra-lesional Glucantime together with cryotherapy. The patients were compared for their environmental, clinical, and demographic characteristics factors. In total, 340 ACL patients consisting of 72 (21.18%) unresponsive and 268 (78.82%) responsive cases were included in the study.

![Unresponsive patients with active skin lesions: a 52 years old woman (A) and an 11 years old child (B).](pone.0192236.g001){#pone.0192236.g001}

Culturing of the organism {#sec008}
-------------------------

A random sub-sampling process was performed to identify the causative agent of CL. Out of the 30 patients in this study, 15 were unresponsive (non-healed) and the remaining were responsive (healed) patients by different foci and month ([Table 1](#pone.0192236.t001){ref-type="table"}). The sampling was performed with the active lesion in both unresponsive and responsive patients. Skin lesions were cleansed with topical antiseptic and aspirated by inserting a 20-gauge needle with a syringe. Promastigotes were grown in Novy-MacNeal-Nicolle (N.N.N) medium at 24±1°C for one week and then sub-cultured in Rosewell Park Memorial Institute (RPMI1640) cell culture medium (Gibco BRL) with 10% inactive fetal calf serum (FCS; Sigma-Aldrich), Penicillin (100 unites/ml), and Streptomicin (100 μg/ml) \[[@pone.0192236.ref015]\]. Promastigotes were collected by 5 min centrifugation at 8000 rpm and the remaining sample was stored at -20°C for further identification tests.

10.1371/journal.pone.0192236.t001

###### The number of isolates that were attempted from unresponsive and responsive cases by different foci and months.

![](pone.0192236.t001){#pone.0192236.t001g}

  Number of isolates   Unresponsive patients   Responsive patients                    
  -------------------- ----------------------- --------------------- ---------------- ----------------
  1                    Sarasiab                August 2015           Sarasiab         August 2015
  2                    Shahrak Pedar           September 2015        Sarbaz St.       September 2015
  3                    Sarasiab                October 2015          Shahrak Pedar    September 2015
  4                    Emam St.                October 2015          Emam St.         September 2015
  5                    Allah abad              October 2015          Allah abad       October 2015
  6                    Shahrak Sanati          October 2015          Sarasiab         October 2015
  7                    Sarasiab                November 2015         Shahrak Sanati   October 2015
  8                    Shahrak Sanati          November 2015         Firozabad        October 2015
  9                    Firozabad               November 2015         Shahab St.       November 2015
  10                   Emam St.                November 2015         Sarasiab         November 2015
  11                   Sarasiab                December 2015         Shahrak Sanati   November 2015
  12                   Shahrak Seyedi          December 2015         Modiriate St.    November 2015
  13                   Shahrak Pedar           December 2015         Allah abad       December 2015
  14                   Shahrak Sanati          January 2016          Shahrak Sanati   December 2015
  15                   Allah abad              January 2016          Sarasiab         December 2015

Molecular identification {#sec009}
------------------------

To identify the parasite species that caused the CL disease in different isolation regions, molecular identification was performed on each cultured sample ([Table 2](#pone.0192236.t002){ref-type="table"}) based on the studies by Schonian et al. (2003) and Van der Auwera et al. (2013) \[[@pone.0192236.ref016],[@pone.0192236.ref017]\], with some modifications. DNA was extracted using High Pure PCR Template Purification Kit (Roche, Germany) and it was quantified with a spectrophotometer (NanoDrop-2000c; Thermo Scientific). Partial amplification of *Hsp*70 and *ITS1* was displayed with specific set of primers ([Table 3](#pone.0192236.t003){ref-type="table"}) followed by the PCR amplification conditions in thermal cycler (Flexcycle 2, Analytikjena, Germany). All amplified samples were sequenced for both directions with Microgen Company, Korea. All amplified samples were sequenced, aligned, and edited by Bioedit ver.7.2 \[[@pone.0192236.ref018]\] and BLAST with online tool (<https://blast.ncbi.nlm.nih.gov/Blast.cgi>) to show the maximum species homology.

10.1371/journal.pone.0192236.t002

###### Distribution of cultured and molecular positivity in uresponsive and responsive pateints.

![](pone.0192236.t002){#pone.0192236.t002g}

  Unresponsive patients   Responsive patients                                                                    
  ----------------------- --------------------- ----------------------------------------------- ---- ----------- -----------------------------------------------
  28                      15 (53.6)             [\*](#t002fn001){ref-type="table-fn"}15 (100)   22   15 (62.2)   [\*](#t002fn001){ref-type="table-fn"}15 (100)

\*Due to low quantity of extracted DNA based on NanoDrop measurement, three specimens' extractions were repeated.

10.1371/journal.pone.0192236.t003

###### Set of applied primer to amplify candidate loci with optimum PCR conditions.

![](pone.0192236.t003){#pone.0192236.t003g}

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Assay        Primer name                Primer sequence         Ref                           Product (bp)   Annealing   PCR condition (final Concentration)   Cycling protocol   Cycling
  ------------ -------------------------- ----------------------- ----------------------------- -------------- ----------- ------------------------------------- ------------------ ---------
  *HSP* 70     F25: 5\'                   `GGACGCCGGCACGATTKCT`   Van der Auwera et al., 2013   1245--1286     60°         200 μM dNTP's\                        Annealing\         35
                                                                                                                           0.8 μM of each PCR primer\            60 sec\            
                                                                                                                           2 U Taq pol\                          Extension:\        
                                                                                                                           1,5 mM MgC12                          120 sec            

  R1310: 5\'   `CCTGGTTGTTGTTCAGCCACTC`                                                                                                                                             

  *ITS1*-PCR   LITSR: 5\'                 `TGGATCATTTTCCGATG`     Schönian et al., 2003         300--350       53°         Annealing\                                               
                                                                                                                           30 sec\                                                  
                                                                                                                           Extension:\                                              
                                                                                                                           60 sec                                                   

  L5.8S: 5\'   `TGATACCACTTATCGCACTT`                                                                                                                                               
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data analysis {#sec010}
-------------

The collected data were entered into a computer using SPSS software (version 20.0, SPSS, Inc., Chicago, IL, USA) and analyzed by univariate and multivariate logistic regression tests. *P* value of less than 0.05 was considered statistically significant.

Univariate logistic regression was used to determine if the variables were proper to be used in multivariate logistic regression. Therefore, variables with *p* value less than 0.2 were picked after the analysis. The main reason for using the multivariate method was that the mentioned variables might be confounders. In this way, their effect could be controlled. Then, the backward elimination stepwise method was used to reach the best possible model. Moreover, it is an additional way to exclude the impacts of confounding variables.

Results {#sec011}
=======

Molecular finding {#sec012}
-----------------

Based on the BLAST and phylogenic analyses of PCR sequences, all isolates were characterized as *L*. *tropica* with high percentage pairwise nucleotide similarity in both *Hsp70* (99 to 100%) and *ITS1* (94 to 99%) loci with other WHO reference strains of *L*. *tropica* ([S2 Table](#pone.0192236.s004){ref-type="supplementary-material"}). Pairwise nucleotide similarity between Kerman isolates and WHO reference strains of *L*. *major* for *Hsp70* and *ITS1* were calculated, 97 to 98% and 84 to 85% based on the BLAST results, respectively. All sequences were submitted in NCBI nucleotide database with GenBank accession numbers KY661706-KY661710.

Risk factor analysis {#sec013}
--------------------

Generally, 340 ACL patients comprising 72 (21.2%) unresponsive and 292 (78.8%) responsive cases with active lesions or scars were analyzed for potential environmental ([Table 4](#pone.0192236.t004){ref-type="table"}), clinical ([Table 5](#pone.0192236.t005){ref-type="table"}), and demographical factors ([Table 6](#pone.0192236.t006){ref-type="table"}). According to univariate and multivariate logistic analyses, 4 major variables of the overall risk factors including poor interior housing conditions, longer duration of lesion, patients with history of chronic diseases, and age groups were significantly associated with the non-healing lesions ([S1 Data](#pone.0192236.s001){ref-type="supplementary-material"}).

10.1371/journal.pone.0192236.t004

###### Odds ratios for potential environmental risk factors with anthroponotic cutaneous leishmaniasis in southeastern Iran.

![](pone.0192236.t004){#pone.0192236.t004g}

  Variable                                            Unresponsive patients   Responsive patients   OR     Univariate95%CI   p-Value   OR     Multivariate95%CI   p-Value
  --------------------------------------------------- ----------------------- --------------------- ------ ----------------- --------- ------ ------------------- ---------
  **Building Condition**                                                                                                                                          
  [^1^](#t004fn001){ref-type="table-fn"} Unsuitable   49                      163                   1.37   0.79--2.38        0.26                                 
  [^2^](#t004fn002){ref-type="table-fn"} Suitable     23                      105                   1                                                             
  **WallCondition**                                                                                                                                               
  Unsuitable                                          55                      192                   1.28   0.69--2.34        0\. 42                               
  Suitable                                            17                      76                    1                                                             
  **Door and window Net**                                                                                                                                         
  No                                                  61                      199                   1.92   0.95--3.86        0.06                                 
  Yes                                                 11                      69                    1                                                             
  **Interior housing condition**                                                                                                                                  
  Unsuitable                                          34                      93                    1.68   0.99--2.85        0.05      1.99   1--3.93             0.04
  Suitable                                            38                      175                   1                                  1                          
  **Out of building toilet**                                                                                                                                      
  No                                                  17                      85                    0.66   0.36--1.21        0.18                                 
  Yes                                                 55                      183                   1                                                             
  **Presence of small garden**                                                                                                                                    
  No                                                  10                      45                    0.79   0.38--1.67        0.55                                 
  Yes                                                 62                      223                   1                                                             
  **Dwelling hygienic condition**                                                                                                                                 
  Unsuitable                                          28                      121                   0.77   0.45--1.31        0.34                                 
  Suitable                                            44                      147                   1                                                             
  **Presenceof palm and orange trees in home**                                                                                                                    
  No                                                  67                      254                   0.73   0.25--2.12        0.57                                 
  Yes                                                 5                       14                    1                                                             
  **Presenceof domestic animal**                                                                                                                                  
  No                                                  38                      160                   0.75   0.44--1.27        0.29                                 
  Yes                                                 34                      108                   1                                                             
  **Presenceof dog in home**                                                                                                                                      
  No                                                  57                      228                   0.66   0.34--1.29        0.22                                 
  Yes                                                 15                      40                    1                                                             
  **Presenceof manure in home**                                                                                                                                   
  No                                                  62                      231                   0.99   0.46--2.1         0.98                                 
  Yes                                                 10                      37                    1                                                             
  **Solid waste management**                                                                                                                                      
  Unsuitable                                          4                       47                    0.27   0.09--0.79        0.01                                 
  Suitable                                            68                      221                   1                                                             
  **Presenceof dog in region**                                                                                                                                    
  No                                                  8                       50                    0.54   0.24--1.2         0.13                                 
  Yes                                                 64                      218                   1                                                             
  **Number of room**                                                                                                                                              
  ≤2                                                  25                      121                   1.29   0.41--4.03        0.66                                 
  3--5                                                43                      122                   2.2    0.72--6.69        0.16                                 
  ≥6                                                  4                       25                    1                                                             
  **Number of window**                                                                                                                                            
  ≤2                                                  2                       2                     3.15   0.43--22.98       0.25                                 
  3--4                                                19                      105                   0.57   0.31--1.02        0.059                                
  ≥5                                                  51                      161                   1                                                             

^1^Unsuitable: Denotes the patients who live in unsuitable housing conditions in terms of building, interior housing, wall and dwelling hygienic conditions and solid waste. If in the living places (building, interior housing and wall), there are cracks and crevices, they are considered unsuitable. If there is garbage and sewage in front of or near the home, it will be considered unsuitable dwelling hygienic condition. If in their place of residence, there is solid waste, it will be considered unsuitable.

^2^Suitable: Denotes the patients who live in suitable housing condition in terms of building, interior housing, wall, dwelling hygienic condition and solid waste management. If in the living places (building, interior housing and wall), there are no cracks and crevices, they are considered suitable. If there is no garbage and sewage in front of or near the home, it will be considered suitable dwelling hygienic condition. If in their place of residence, there is solid waste management, it will be considered suitable.

10.1371/journal.pone.0192236.t005

###### Odds ratios for potential clinical status risk factors with anthroponotic cutaneous leishmaniasis in southeastern Iran.

![](pone.0192236.t005){#pone.0192236.t005g}

  Variable                                                     Unresponsive patients   Responsive patients   OR      Univariate95%CI   p-Value   OR      Multivariate95%CI   p-Value
  ------------------------------------------------------------ ----------------------- --------------------- ------- ----------------- --------- ------- ------------------- ---------
  **Location of lesion**                                                                                                                                                     
  Hands                                                        25                      145                   0.66    0.27--1.62        0.37                                  
  Face                                                         38                      68                    2.16    0.9--5.18         0.08                                  
  Legs                                                         1                       24                    0.16    0.01--1.38        0.09                                  
  Other                                                        8                       31                    1                                                               
  **Treatmentcondition**                                                                                                                                                     
  [^1^](#t005fn001){ref-type="table-fn"} Incompletetreatment   16                      55                    1.1     0.58--2.07        0.75                                  
  [^2^](#t005fn002){ref-type="table-fn"} Complete treatment    56                      213                   1                                                               
  **History of chronic disease**                                                                                                                                             
  Yes                                                          22                      26                    4.09    2.15--7.8         ≤0.001    6.22    2.51--15.44         ≤0.001
  No                                                           50                      242                   1                                   1                           
  **Duration of lesion (month)**                                                                                                                                             
  ≤4                                                           7                       141                   1                                   1                           
  5--12                                                        47                      123                   7.69    3.35--17.65       ≤0.001    7.42    3.07--17.92         ≤0.001
  ≥13                                                          18                      4                     90.64   24.14--340.26     ≤0.001    74.99   17.24--326.17       ≤0.001
  **Number of lesion**                                                                                                                                                       
  ≤2                                                           65                      225                   1.77    0.76--4.13        0.18                                  
  ≥3                                                           7                       43                    1                                                               

^1^Incomplete treatment: The patients who did not receive a course of intramuscular (IM) treatment (20 mg/kg/daily for 3 weeks) or intralesional (IL) along with cryotherapy (20 mg/kg/weekly for a maximum of 12 weeks).

^2^Completed treatment: The patients who received a course of treatment.

10.1371/journal.pone.0192236.t006

###### Odds ratios for potential demographical risk factors with anthroponotic cutaneous leishmaniasis in southeastern Iran.

![](pone.0192236.t006){#pone.0192236.t006g}

  Variable                               Unresponsive patients   Responsive patients   OR     Univariate95%CI   p-Value   OR     Multivariate95%CI   p-Value
  -------------------------------------- ----------------------- --------------------- ------ ----------------- --------- ------ ------------------- ---------
  **Age (year)**                                                                                                                                     
  ≤7                                     19                      65                    1                                  1                          
  8--15                                  18                      82                    0.75   0.36--1.54        0.43      0.65   0.25--1.67          0.37
  16--30                                 13                      56                    0.79   0.36--1.75        0.56      1.03   0.37--2.87          0.95
  31--50                                 13                      49                    0.9    0.4--2.01         0.81      0.8    0.28--2.23          0.47
  ≥51                                    9                       16                    1.92   0.73--5.04        0.18      3.85   1.04--14.22         0.04
  **Sex**                                                                                                                                            
  Female                                 30                      134                   0.71   0.42--1.2         0.21                                 
  Male                                   42                      134                   1                                                             
  **Education**                                                                                                                                      
  Illiterate                             31                      78                    3.06   1.4--6.67         0.005                                
  Primary and Secondary education        31                      113                   2.11   0.97--4.55        0.05                                 
  High school and university education   10                      77                    1                                                             
  **Job**                                                                                                                                            
  Unemployed                             6                       44                    2.16   0.88--5.29        0.09                                 
  Employed                               66                      224                   1                                                             
  **Marital status**                                                                                                                                 
  Single                                 57                      178                   1.92   1.03--3.58        0.04                                 
  Married                                15                      90                    1                                                             

The odds of unresponsive form in patients with unsuitable interior housing condition were significantly higher than in patients with suitable interior housing condition (OR = 1.99, CI = 1.00--3.93, *P*\<0.04). The risk of patients with history of chronic diseases was the major factor which had a more profound impact on unresponsive form when compared with patients having no history of chronic diseases (OR = 6.22, CI = 2.51--15.44, *P*≤0.001). Patients referred ≥13 months following the onset of lesion (OR = 74.99, CI = 17.24--326.17, *P*≤0.001) and 5 to 12-months old (OR = 7.24, CI = 3.07--17.92, *P*≤0.001) had significantly higher odds than those ≤4 months duration of lesion. Similarly, patients aged ≥51 years (OR = 3.85, CI = 1.04--14.22, *P*\<0.04) demonstrated significantly higher odds than those ≤7 years. Other risk factors including building, wall, door, and window conditions, out of building toilet, presence of small garden, dwelling hygienic condition, number of windows, rooms, domestic animals, dog, manure in home, solid waste management, presence of dog in close vicinity, number and location of the lesions, treatment condition, sex, education, job, and marital status were not significantly associated with the incidence of non-healing lesions (*P*\>0.05).

Discussion {#sec014}
==========

Cutaneous leishmaniasis is one of the most serious health problems in Iran, especially in Kerman province, southeastern Iran \[[@pone.0192236.ref005],[@pone.0192236.ref019]\]. Previous studies have shown that CL in Kerman district was predominantly of ACL type. Similarly, the majority of the cases which occurred in southern districts were ACL \[[@pone.0192236.ref019]\]. However, in this study, attempt was made to use molecular methods powered by sequencing amplification regions of *Hsp*70 and *ITS1* to identify the *Leishmania* isolates. Nucleotide polymorphism as discriminative molecular marker in these regions is highly recommended \[[@pone.0192236.ref017],[@pone.0192236.ref020]--[@pone.0192236.ref022]\]. Based on the method used, all samples were *L*. *tropica*, due to the widespread prevalence of this endemic species in this area.

Human health is significantly affected by housing and environmental conditions \[[@pone.0192236.ref013],[@pone.0192236.ref023]\]. In the present study, poor interior housing condition was also identified as a risk factor among unresponsive patients with ACL. The results of the present study showed that creation of unresponsive forms in patients with unsuitable interior housing condition was significantly higher than those with suitable interior housing condition (*P*\<0.05). The rate of sand flies in the cracks and crevices of walls and ceilings in unsuitable houses is higher than suitable ones \[[@pone.0192236.ref024],[@pone.0192236.ref025]\]. This study showed that there was a positive association between the rate of unresponsiveness in ACL and poor interior housing conditions. The people who live in unsuitable interior housing condition in endemic areas are more susceptible to infection with CL, due to the presence of parasite and suitable condition for propagation of sand fly vectors \[[@pone.0192236.ref024],[@pone.0192236.ref025]\]. Generally, these individuals belong to low income and poor social class. Therefore, they provide their needs in difficulty and are always looking for a job. These people in case of infection with CL receive their treatment too late or do it irregularly and disregard the disease consequences. It seems that owing to the prolonged duration of the disease, irregular and untimely treatment, the probability of developing unresponsive forms increases in these individuals.

Efforts are being made to sensitize patients in order to complete treatment. Treatment results being poorly defined make it difficult to report on this indicator \[[@pone.0192236.ref008]\]. In our investigation, among the patients who had started treatment after a long time or with incomplete treatment, had greater odds than those who started treatment after a short onset of the disease (*P*≤0.001). Due to lack of active-case detection approaches and awareness among the inhabitants, arbitrary treatments, and lack of medical care, the disease was not early detected. Hence, the treatment began at least 4 months thereafter. Therefore, in this group, the treatment procedure was more complicated and difficult. Incomplete or CL unsuccessful treatment is sometimes due to increased drug resistance of the *Leishmania* \[[@pone.0192236.ref026],[@pone.0192236.ref027]\].

The pathogenesis of the increased prevalence of infection in patients with the history of chronic diseases such as diabetes and opium addiction is affected by the role of innate immune response. Patients with diabetes mellitus (DM) have been more infected than those without DM. Therefore, the increased prevalence of infections could be due to deficiency in immunity \[[@pone.0192236.ref028],[@pone.0192236.ref029]\]. It is noteworthy that opium as an important public health problem is common in southeastern Iran and neighboring countries \[[@pone.0192236.ref012]\]. A recent study in 2016 showed that CL lesions in opium addicted patients were more severe than the control group in terms of the size, number, and duration of lesions \[[@pone.0192236.ref012]\]. However, the causes of the difference in severity of the lesions are not yet well recognized. According to Sacerdote et al. (1997) and Wei et al. (2003), a significant immunosuppressive effect could be exerted by opioids including morphine and heroin, derivative of opium alkaloids \[[@pone.0192236.ref030],[@pone.0192236.ref031]\]. Also, morphine disturbs phagocytic cell role, natural killer cell function, antibody production, cell-mediated immunity, nitrogen intermediates, and reactive oxygen \[[@pone.0192236.ref032]--[@pone.0192236.ref036]\]. In the present study, patients with the history of diabetes, opium addiction, hypertension/high blood pressure, cardiovascular problems, and tuberculosis, developed more significantly unresponsive forms than those without history of chronic diseases (*P≤0*.*001*).

In several countries where the number of local people is low or the population is frequently altered, all age groups are affected \[[@pone.0192236.ref037]--[@pone.0192236.ref039]\]. Also, in Kerman, ACL cases have been reported in all age groups, although children in colder seasons contracted the disease more frequently than the older individuals \[[@pone.0192236.ref040]\]. The present study showed that unresponsiveness in ACL was significantly associated with the increasing age (*P\<0*.*05*). Probably, defect in cellular innate immunity due to various factors such as chronic diseases plays a role in the pathogenesis of the increased unresponsive forms in patients in older age groups. The control of CL is interceded by cellular immune responses. It is worth noting that human life styles alternations, environmental condition, immune responses, treatment failure and drug resistance are potential factors that could affect the prevalence of CL \[[@pone.0192236.ref009],[@pone.0192236.ref023],[@pone.0192236.ref041],[@pone.0192236.ref042]\].

Conclusion {#sec015}
==========

In this study, four major risk factors, including interior housing conditions, history of chronic diseases, duration of lesion, and age groups were significantly associated with the development of unresponsive forms. Improving interior house construction, early detection and effective treatment, protecting persons and those with debilitating diseases from being bitten by sand flies, especially in older age groups with the history of chronic diseases are exceedingly important measures for prevention of unresponsive forms of ACL in southeastern Iran. To prevent the disease, it is therefore essential that the national health authorities implement appropriate control strategies.
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